Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

The American College of Gastroenterology has released a new clinical guideline with 18 recommendations aimed at preventing complications in patients with cirrhosis. Key guidance covers HCC surveillance, variceal management, vaccinations, and lifestyle interventions like nutrition and exercise. The goal: improve both the quality and length of life for cirrhosis patients through earlier, more consistent preventive action.
The American College of Gastroenterology (ACG) has published a comprehensive clinical guideline on preventive care for patients with cirrhosis, targeting four key domains: cirrhosis-specific complications, infection prevention, lifestyle factors, and non-liver conditions like osteoporosis and extrahepatic cancer. The guideline, led by hepatologist Dr. Elliot B. Tapper of Michigan Medicine, includes 18 recommendations and six key concept statements designed to close well-documented gaps in cirrhosis care.
On the clinical side, strong recommendations include carvedilol or esophageal variceal ligation for high-risk varices, semiannual HCC surveillance with ultrasound and alpha-fetoprotein testing, and short-course antibiotics for upper GI bleeding. Conditional recommendations cover lactulose for minimal hepatic encephalopathy, adjunctive rifaximin after hospitalization for overt HE, and bisphosphonates for osteoporosis. Vaccination against hepatitis A, hepatitis B, influenza, COVID-19, and RSV (for patients over 50) is also strongly recommended.
Key Takeaways:
Why it matters: Cirrhosis prognosis improves dramatically with early-stage intervention, yet care consistently falls short in practice. This guideline gives clinicians a concrete, actionable roadmap to reduce hospitalizations, prevent infections, and extend patients' lives.